Cargando…
Mechanisms and Control Measures of Mature Biofilm Resistance to Antimicrobial Agents in the Clinical Context
[Image: see text] Biofilms are the aggregation of micro-organisms, which are composed of extracellular polymeric substance (EPS) and many other biochemical components. Though they might be beneficial to some wastewater and soil treatment processes, they may expose chronic infection and risk to perso...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495453/ https://www.ncbi.nlm.nih.gov/pubmed/32954115 http://dx.doi.org/10.1021/acsomega.0c02294 |
_version_ | 1783582926030503936 |
---|---|
author | Li, Yuanzhe Xiao, Peng Wang, Yilin Hao, Yu |
author_facet | Li, Yuanzhe Xiao, Peng Wang, Yilin Hao, Yu |
author_sort | Li, Yuanzhe |
collection | PubMed |
description | [Image: see text] Biofilms are the aggregation of micro-organisms, which are composed of extracellular polymeric substance (EPS) and many other biochemical components. Though they might be beneficial to some wastewater and soil treatment processes, they may expose chronic infection and risk to personal hygiene in the industrial as well as the clinical context. Despite having a well-established disinfection and hygiene monitoring program for the prevention of formation and growth, biofilm persistently remains in the medical settings because of its antibiotic resistance to antimicrobial agents and even the immune system. In this paper, the contributing factors of antibiotic resistance and the corresponding mechanisms, including heterogeneity inside biofilms, the roles of the EPS matrix, cell density, and quorum sensing, and cell mutability, are reviewed. Moreover, current clinical practice and strategic applications are also suggested to address the biofilm resistance issues. |
format | Online Article Text |
id | pubmed-7495453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-74954532020-09-18 Mechanisms and Control Measures of Mature Biofilm Resistance to Antimicrobial Agents in the Clinical Context Li, Yuanzhe Xiao, Peng Wang, Yilin Hao, Yu ACS Omega [Image: see text] Biofilms are the aggregation of micro-organisms, which are composed of extracellular polymeric substance (EPS) and many other biochemical components. Though they might be beneficial to some wastewater and soil treatment processes, they may expose chronic infection and risk to personal hygiene in the industrial as well as the clinical context. Despite having a well-established disinfection and hygiene monitoring program for the prevention of formation and growth, biofilm persistently remains in the medical settings because of its antibiotic resistance to antimicrobial agents and even the immune system. In this paper, the contributing factors of antibiotic resistance and the corresponding mechanisms, including heterogeneity inside biofilms, the roles of the EPS matrix, cell density, and quorum sensing, and cell mutability, are reviewed. Moreover, current clinical practice and strategic applications are also suggested to address the biofilm resistance issues. American Chemical Society 2020-08-28 /pmc/articles/PMC7495453/ /pubmed/32954115 http://dx.doi.org/10.1021/acsomega.0c02294 Text en Copyright © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Li, Yuanzhe Xiao, Peng Wang, Yilin Hao, Yu Mechanisms and Control Measures of Mature Biofilm Resistance to Antimicrobial Agents in the Clinical Context |
title | Mechanisms and Control Measures of Mature Biofilm Resistance to Antimicrobial
Agents in the Clinical Context |
title_full | Mechanisms and Control Measures of Mature Biofilm Resistance to Antimicrobial
Agents in the Clinical Context |
title_fullStr | Mechanisms and Control Measures of Mature Biofilm Resistance to Antimicrobial
Agents in the Clinical Context |
title_full_unstemmed | Mechanisms and Control Measures of Mature Biofilm Resistance to Antimicrobial
Agents in the Clinical Context |
title_short | Mechanisms and Control Measures of Mature Biofilm Resistance to Antimicrobial
Agents in the Clinical Context |
title_sort | mechanisms and control measures of mature biofilm resistance to antimicrobial
agents in the clinical context |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495453/ https://www.ncbi.nlm.nih.gov/pubmed/32954115 http://dx.doi.org/10.1021/acsomega.0c02294 |
work_keys_str_mv | AT liyuanzhe mechanismsandcontrolmeasuresofmaturebiofilmresistancetoantimicrobialagentsintheclinicalcontext AT xiaopeng mechanismsandcontrolmeasuresofmaturebiofilmresistancetoantimicrobialagentsintheclinicalcontext AT wangyilin mechanismsandcontrolmeasuresofmaturebiofilmresistancetoantimicrobialagentsintheclinicalcontext AT haoyu mechanismsandcontrolmeasuresofmaturebiofilmresistancetoantimicrobialagentsintheclinicalcontext |